WIPO trademark

TRUEMRD

MixedWIPOClass 1Class 5Class 42Class 44

"TRUEMRD" is a trademark owned by Veracyte, Inc., filed at the WIPO on July 1, 2025. It is on file and covers classes 1, 5, 42 and 44.

TRUEMRD
Trademark as filed with the WIPO
Status
Mixed
Filed
July 1, 2025
Registered
Not yet
Expires
July 1, 2035
Application no.
Not recorded
Registration no.
1904546
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
4 classes
Ownership

Who owns TRUEMRD

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Veracyte, Inc.

VCYT · United States

52 trademarks in the portfolioView company

Representative

Gowling WLG (Canada) LLP

Gowling WLG (Canada) LLP

Goods and services

What the mark covers

The products and services TRUEMRD is filed for, grouped by Nice class.

  • Reagents for scientific or research use; diagnostic kits and test kits primarily composed of reagents for determination of genomic and transcriptomic information for scientific or research purposes; testing kits comprised primarily of preparations, reagents, test strips, buffers, and assays; biological agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; diagnostic reagents and preparations, other than for medical and veterinary use; kits comprised primarily of biological reagents; tests designed to isolate and extract nucleic acids for genomic analysis comprised of reagents for scientific or research purposes; reagents and molecule or cell markers for scientific or research purposes; whole genome sequencing tests, namely, for scientific or research purposes.

  • Kits for in vitro diagnostic testing for cancers and other diseases; reagents for medical use; molecular diagnostic assays for testing of bodily fluids, tissue, cells, blood, disease, cancer, genetics, genomics, and pathogens; diagnostic medical preparations for use in the field of bodily fluids, tissue, cells, blood, disease, cancer, genetics, genomics, and pathogens; diagnostic agents, preparations and substances for medical purposes; diagnostic test kits consisting primarily of reagents for use in testing bodily fluids, tissue, cells, blood, disease, cancer, genetics, genomics, and pathogens; medical diagnostic test kits consisting primarily of reagents for detecting pathogens; clinical medical diagnostic reagents, medical diagnostic assays for medical and diagnostic purposes for testing nucleic acid material; chemicals, assays, reagents and kits consisting primarily of chemicals, assays, and reagents for medical testing and diagnostic purposes in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genomics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; medical diagnostic reagents, and kits comprised of medical diagnostic reagents, buffers; medical diagnostic testing kits comprised primarily of reagents and assays for use in diagnostics and diagnostic testing in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genomics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; tests designed to isolate and extract cells for genomic analysis comprised of reagents for medical diagnostic use; whole genome sequencing tests, namely, for medical and diagnostic purposes.

  • Clinical medical research; clinical research in the field of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research trials and studies, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genomics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; scientific laboratory research; scientific laboratory services; scientific laboratory testing services for disease, cancer, genetics, genomics, and pathogens; scientific laboratory testing and testing, analysis, monitoring, and results reporting services for use in research and development for oncology, cancers, and diseases; scientific and medical research and development services; research and development services for others in the field of diagnostic tests, chemicals, compounds and devices; research and development of new diagnostic tests, clinical products, diagnostic agents and assays; nucleic acid sequencing, screening, and analysis services for medical research purposes; genomic and transcriptomic sequencing, screening, and analysis services for medical research purposes; genomic analysis and reporting services for medical research purposes; providing medical research services for others featuring research in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genomics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; chemical screening analysis and diagnostic services for others for scientific research purposes; scientific and technological research in the field of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genomics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases and diagnostic services for scientific research purposes; advisory, consultative and telephone help desk services relating to the use of assays and reagents for use in biochemical analysis and diagnostic services; information and advisory services in the fields of medical research, clinical research, medical laboratory research, and scientific research in the fields of laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genomics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; providing online non-downloadable computer software for medical diagnostics and research in the field of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genomics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, lung cancer, breast cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; providing online non-downloadable software for data collection, management, and analysis of genomic information for use in the fields of diagnostic and clinical research and for clinical diagnostic purposes; providing online non-downloadable software for use in data analysis in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genomics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; whole genome sequencing testing for scientific or research purposes.

  • Medical services; medical diagnostic testing services; medical testing for diagnostic or treatment purposes; medical analysis services for diagnostic and treatment purposes; medical diagnostic testing services in the fields of oncology, cancer, and diseases; genomic analysis and reporting services for medical diagnostic purposes; medical diagnostic testing, monitoring and reporting services in the fields of diagnostics, medical diagnostics, clinical diagnostics, companion diagnostics, medical treatment, medical research, clinical research, medical laboratory research, laboratory medicine, genetic testing, nucleic acid sequencing, genetics, genomics, genotyping, life sciences, biology, oncology, cancers, thyroid cancer, breast cancer, lung cancer, prostate cancer, bladder cancer, kidney cancer, colon cancer, interstitial lung diseases, lymphoma, diseases, infectious diseases, and related diseases; nucleic acid sequencing and analysis services for medical diagnostic and treatment purposes; genomic and transcriptomic sequencing and analysis services for medical diagnostic and treatment purposes; genomic analysis and reporting services for medical diagnostic and treatment purposes; whole genome sequencing for medical detection, diagnosis, prognosis, prediction, and treatment purposes.

FAQ

About TRUEMRD

Who owns the trademark "TRUEMRD"?

The WIPO trademark "TRUEMRD" is owned by Veracyte, Inc.

What is the status of "TRUEMRD"?

Its status at the WIPO is: mixed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull TRUEMRD and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_a26d39c3-9c60-4f7f-994c-6dfeb2b92cae
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_a26d39c3-9c60-4f7f-994c-6dfeb2b92cae",
  "object": "trademark",
  "mark_text": "TRUEMRD",
  "status": {
    "primary": "mixed",
    "stage": "mixed"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2025-07-01",
  "nice_classes": [
    1,
    5,
    42,
    44
  ],
  "owners": [
    {
      "name": "VERACYTE, INC.",
      "entity_id": "ent_019eb70a-1e57-7233-9f09-080dbab28cb9"
    }
  ]
}